ALPMY:OTCMKTS
Astellas Pharma ADR Representing 1 Ord Shs
$14.35
0.00%
(0.00) 1D
$14.35
0.00% (0.00)
bedtimeAfter hours
Closed: Oct 12, 4:00:00 PM GMT-4 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for ALPMY...
Open
$13.48
High
$14.35
Low
$13.48
Mkt. cap
4.16T
Avg. vol.
102.64K
Volume
114.45K
52-wk high
$17.35
52-wk low
$10.03
Beta
0.13
Shares outstanding
1.81B
No. of employees
14K
Open
$13.48
High
$14.35
Low
$13.48
Mkt. cap
4.16T
Avg. vol.
102.64K
Volume
114.45K
52-wk high
$17.35
52-wk low
$10.03
Beta
0.13
Shares outstanding
1.81B
No. of employees
14K
News stories
From web sources and news partners
Business Wire
·
17 minutes ago
Powerus (Nasdaq: PUSA) Unveils Fully Autonomous Drone Interceptors at AUSA 2026
PR Newswire
·
17 minutes ago
NeuroSense Secures Nasdaq Hearing Date as PrimeC Approaches Key Regulatory and Funding Milestones
The National Law Review
·
15 minutes ago
XCF Global (Nasdaq:SAFX) Announces $12M+ in Gross Product Sales a
WSJ
·
49 minutes ago
Nasdaq Futures Fall as Global AI Selloff Intensifies
Profile
Astellas Pharma Inc. is a Japanese multinational pharmaceutical company, formed on 1 April 2005 from the merger of Yamanouchi Pharmaceutical Co., Ltd. and Fujisawa Pharmaceutical Co., Ltd.
Astellas is a member of the Mitsubishi UFJ Financial Group keiretsu. Wikipedia
About Astellas Pharma ADR Representing 1 Ord Shs
CEONaoki Okamura
Employees14.1K
FoundedApr 1, 2005
HeadquartersChuo City, Tokyo, Japan
SectorPharmaceutical industry
Websiteastellas.com